Literature DB >> 23766442

Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics.

Venessa Eeckhaut1, Richard Ducatelle, Benedikt Sas, Séverine Vermeire, Filip Van Immerseel.   

Abstract

Entities:  

Keywords:  INFLAMMATORY BOWEL DISEASE; PROBIOTICS

Mesh：

Year:  2013        PMID： 23766442     DOI： 10.1136/gutjnl-2013-305293

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  14 in total

Review 1.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 2.  Probiotics in human health and disease: from nutribiotics to pharmabiotics.

Authors:  Eun-Sook Lee; Eun-Ji Song; Young-Do Nam; So-Young Lee
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

3.  Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.

Authors:  Zoltan Pataky; Laurence Genton; Laurent Spahr; Vladimir Lazarevic; Sylvain Terraz; Nadia Gaïa; Laura Rubbia-Brandt; Alain Golay; Jacques Schrenzel; Claude Pichard
Journal:  Dig Dis Sci       Date:  2016-05-03       Impact factor: 3.199

4.  Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats.

Authors:  Mingming Zhang; Qian Zhou; Robert G Dorfman; Xiaoli Huang; Tingting Fan; Hao Zhang; Jun Zhang; Chenggong Yu
Journal:  BMC Gastroenterol       Date:  2016-07-30       Impact factor: 3.067

5.  Wheat Bran Does Not Affect Postprandial Plasma Short-Chain Fatty Acids from 13C-inulin Fermentation in Healthy Subjects.

Authors:  Lise Deroover; Joran Verspreet; Anja Luypaerts; Greet Vandermeulen; Christophe M Courtin; Kristin Verbeke
Journal:  Nutrients       Date:  2017-01-20       Impact factor: 5.717

6.  Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model.

Authors:  Chiara Dianzani; Federica Foglietta; Benedetta Ferrara; Arianna Carolina Rosa; Elisabetta Muntoni; Paolo Gasco; Carlo Della Pepa; Roberto Canaparo; Loredana Serpe
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

7.  Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.

Authors:  Minna Wu; Yaqi Wu; Baoguo Deng; Jinsong Li; Haiying Cao; Yan Qu; Xinlai Qian; Genshen Zhong
Journal:  Oncotarget       Date:  2016-12-20

8.  Effects of Helicobacter suis γ-glutamyl transpeptidase on lymphocytes: modulation by glutamine and glutathione supplementation and outer membrane vesicles as a putative delivery route of the enzyme.

Authors:  Guangzhi Zhang; Richard Ducatelle; Frank Pasmans; Katharina D'Herde; Liping Huang; Annemieke Smet; Freddy Haesebrouck; Bram Flahou
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium.

Authors:  Qianpeng Zhang; Yanqiu Wu; Jing Wang; Guojun Wu; Wenmin Long; Zhengsheng Xue; Linghua Wang; Xiaojun Zhang; Xiaoyan Pang; Yufeng Zhao; Liping Zhao; Chenhong Zhang
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

Review 10.  Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut.

Authors:  Audrey Rivière; Marija Selak; David Lantin; Frédéric Leroy; Luc De Vuyst
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.